lu-208075 and Skin-Ulcer

lu-208075 has been researched along with Skin-Ulcer* in 3 studies

Trials

1 trial(s) available for lu-208075 and Skin-Ulcer

Article	Year
Effect of the endothelin type A-selective endothelin receptor antagonist ambrisentan on digital ulcers in patients with systemic sclerosis: results of a prospective pilot study. Journal of the American Academy of Dermatology, 2014, Volume: 71, Issue:2 Topics: Adult; Endothelin A Receptor Antagonists; Female; Fingers; Humans; Male; Middle Aged; Phenylpropionates; Pilot Projects; Prospective Studies; Pyridazines; Scleroderma, Systemic; Skin Ulcer	2014

Article

Year

Effect of the endothelin type A-selective endothelin receptor antagonist ambrisentan on digital ulcers in patients with systemic sclerosis: results of a prospective pilot study.

Journal of the American Academy of Dermatology, 2014, Volume: 71, Issue:2

Topics: Adult; Endothelin A Receptor Antagonists; Female; Fingers; Humans; Male; Middle Aged; Phenylpropionates; Pilot Projects; Prospective Studies; Pyridazines; Scleroderma, Systemic; Skin Ulcer

2014

Other Studies

2 other study(ies) available for lu-208075 and Skin-Ulcer

Article	Year
Challenges in measuring outcomes: size assessment of an individual cutaneous lesion. Journal of the American Academy of Dermatology, 2014, Volume: 71, Issue:2 Topics: Endothelin A Receptor Antagonists; Female; Humans; Male; Phenylpropionates; Pyridazines; Scleroderma, Systemic; Skin Ulcer	2014
Efficacy of ambrisentan in the treatment of digital ulcers in patients with systemic sclerosis: a preliminary study. Rheumatology (Oxford, England), 2013, Volume: 52, Issue:6 Topics: Adult; Aged; Humans; Middle Aged; Off-Label Use; Phenylpropionates; Pilot Projects; Pyridazines; Scleroderma, Systemic; Skin Ulcer; Treatment Outcome	2013